Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30002756
Basic Information
VIS ID
TVIS30002756
Fusion event
HIV-ZNF652 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr17
Cytoband
q21.33
Reference genome
GRCh37/hg19
Start
47409098/49331736 (Hg38)
End
47409098/49331736 (Hg38)
Orient
+
Location type
Intronic
Target gene
ZNF652
miRNAs that regulate target gene
hsa-mir-155-5p
;
hsa-mir-186-5p
;
hsa-mir-132-3p
;
hsa-mir-128-3p
;
hsa-mir-221-3p
;
hsa-mir-215-5p
;
hsa-mir-181a-5p
;
hsa-mir-192-5p
;
hsa-mir-26b-5p
;
hsa-let-7e-5p
;
hsa-let-7b-5p
;
hsa-mir-548c-3p
;
hsa-mir-203a-3p
;
hsa-mir-7703
;
hsa-mir-548a-3p
;
hsa-mir-548e-3p
;
hsa-mir-548f-3p
;
hsa-mir-548ar-3p
;
hsa-mir-548az-3p
;
hsa-mir-26a-1-3p
;
hsa-mir-26a-2-3p
;
hsa-mir-6731-3p
;
hsa-mir-4639-5p
;
hsa-mir-5580-3p
;
hsa-mir-421
;
hsa-mir-3065-5p
;
hsa-mir-548s
;
hsa-mir-3190-5p
;
hsa-mir-3672
;
hsa-mir-6864-3p
;
hsa-mir-4695-3p
;
hsa-mir-548v
;
hsa-mir-379-3p
;
hsa-mir-382-5p
;
hsa-mir-218-5p
;
hsa-mir-431-5p
;
hsa-mir-654-3p
;
hsa-mir-548t-3p
;
hsa-mir-548ap-3p
;
hsa-mir-548aa
;
hsa-mir-571
;
hsa-mir-519c-3p
;
hsa-mir-519b-3p
;
hsa-mir-519a-3p
;
hsa-mir-548t-5p
;
hsa-mir-548az-5p
;
hsa-mir-219a-1-3p
;
hsa-mir-526b-3p
;
hsa-mir-93-5p
;
hsa-mir-519d-3p
;
hsa-mir-20b-5p
;
hsa-mir-20a-5p
;
hsa-mir-106b-5p
;
hsa-mir-17-5p
;
hsa-mir-106a-5p
;
hsa-mir-548x-3p
;
hsa-mir-548j-3p
;
hsa-mir-548aq-3p
;
hsa-mir-548am-3p
;
hsa-mir-548aj-3p
;
hsa-mir-548ah-3p
;
hsa-mir-548ae-3p
;
hsa-mir-4658
;
hsa-mir-6790-5p
;
hsa-mir-4758-5p
;
hsa-mir-1238-5p
;
hsa-mir-98-3p
;
hsa-let-7f-1-3p
;
hsa-let-7b-3p
;
hsa-let-7a-3p
;
hsa-mir-187-5p
;
hsa-mir-4745-5p
;
hsa-mir-4666a-3p
;
hsa-mir-4481
;
hsa-mir-381-3p
;
hsa-mir-300
;
hsa-mir-222-3p
;
hsa-mir-140-5p
;
hsa-mir-4798-5p
;
hsa-mir-889-3p
;
hsa-mir-5692b
;
hsa-mir-5692c
;
hsa-mir-302f
;
hsa-mir-5692a
;
hsa-mir-580-3p
;
hsa-mir-124-5p
;
hsa-mir-539-5p
;
hsa-mir-505-3p
;
hsa-mir-7159-5p
;
hsa-mir-4272
;
hsa-mir-548z
;
hsa-mir-548h-3p
;
hsa-mir-548d-3p
;
hsa-mir-548bb-3p
;
hsa-mir-548ac
;
hsa-mir-384
;
hsa-mir-3685
;
hsa-mir-202-5p
;
hsa-mir-337-3p
;
hsa-mir-3927-5p
;
hsa-mir-6720-5p
;
hsa-mir-6512-3p
;
hsa-mir-196a-3p
;
hsa-mir-4252
;
hsa-mir-4793-3p
;
hsa-mir-4673
;
hsa-mir-766-3p
;
hsa-mir-4645-5p
;
hsa-mir-6849-3p
;
hsa-mir-1273g-3p
;
hsa-mir-4742-5p
;
hsa-mir-5685
;
hsa-mir-4690-3p
;
hsa-mir-508-5p
;
hsa-mir-7641
;
hsa-mir-6749-3p
;
hsa-mir-6792-3p
;
hsa-mir-4691-5p
;
hsa-mir-138-1-3p
;
hsa-mir-5699-3p
;
hsa-mir-4421
;
hsa-mir-6748-3p
;
hsa-mir-660-3p
;
hsa-mir-4284
;
hsa-mir-2276-3p
;
hsa-mir-4638-5p
;
hsa-mir-1307-3p
;
hsa-mir-6741-3p
;
hsa-mir-1304-3p
;
hsa-mir-4485-5p
;
hsa-mir-6890-3p
;
hsa-mir-1228-5p
;
hsa-mir-513b-5p
;
hsa-mir-654-5p
;
hsa-mir-541-3p
;
hsa-mir-3926
;
hsa-mir-769-5p
;
hsa-mir-4786-5p
;
hsa-mir-4433a-3p
;
hsa-mir-4459
;
hsa-mir-4768-3p
;
hsa-mir-125b-2-3p
;
hsa-mir-4457
;
hsa-mir-624-3p
;
hsa-mir-5583-3p
;
hsa-mir-3974
Nearest miRNA
hsa-mir-10226/Upstream/43282; hsa-mir-1250/Downstream/179081;
Nearest TSS
ENST00000595228/Upstream/41876;
ENST00000507337/Downstream/29429;
Nearest CpG islands
None/Target,
chr17-CpG: 26/Upstream/71105
,
chr17-CpG: 122/Downstream/29808
Upstream sequence
attttataaaaaataaaaaaataaaaaaataaaaatCACAAATATTTTAGATTTGTGGATAACATCAGAAAATGCTGGGAATTTATTTTATACATTTGGC
Downstream sequence
CTACAAAAAGACAAAGGAGTGTTATTGTTTTCTCATTAACAAAAATTTTTTGACACTTCAAAAATTAACATTTTGTATaaaaattagccatgcatggtag
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate